L3MBTL3

L3MBTL3 is a methyllysine-reader protein that couples recognition of mono-/dimethylated lysines to two distinct gene-regulatory outputs: targeted protein degradation and transcriptional corepression (PMID:23292653, PMID:29691401). Through its MBT domains it engages mono- and dimethyllysine marks in a polyvalent binding mode, a function defined structurally and dissected with the chemical probe UNC1215 and Kme-binding point mutants (PMID:23292653). As a proteolysis adapter, L3MBTL3 reads methylated lysines on non-histone substrates and recruits the CRL4DCAF5 ubiquitin E3 ligase to drive their proteasomal degradation: it binds DNMT1-K142me to control DNMT1 turnover, genomic DNA methylation, and embryonic viability, and similarly targets methylated SOX2 (K42) to regulate embryonic stem cell self-renewal and pluripotency (PMID:29691401, PMID:30442713). Independently of its degradation role, L3MBTL3 is a transcriptional corepressor of Notch target genes, binding RBPJ/CBF1 via an unusual interface and competing with the Notch intracellular domain to instead recruit the histone demethylase KDM1A/LSD1 and demethylate H3K4me2 at target enhancers, with the structural basis defined by a 2.06 Å RBPJ-L3MBTL3-DNA crystal structure (PMID:29030483, PMID:36477367). L3MBTL3 also supports transcriptional and degradative functions that do not require its methyllysine-reading activity, including a methylation-independent interaction with STAT3 that activates SNAIL transcription to promote epithelial-mesenchymal transition (PMID:39747894), and a hypoxia-induced negative feedback loop in which it promotes HIF-1α ubiquitination and degradation (PMID:36747531).

1. 2013 High

   Established that L3MBTL3 is a methyllysine reader, defining the biochemical activity underlying all its downstream roles and providing a chemical-genetic tool to probe it.

   Evidence X-ray crystallography of the L3MBTL3-UNC1215 complex, in vitro binding (Kd = 120 nM), point mutagenesis, and cellular probe pulldown of endogenous L3MBTL3

   PMID:23292653 PMID:24040942

   Open questions at the time

   • Physiological methylated substrates were not yet identified at this stage
   • BCLAF1 interaction reported but not mechanistically pursued
2. 2017 High

   Showed L3MBTL3 is a transcriptional corepressor that converts the reader activity into chromatin regulation, answering how RBPJ represses Notch targets in the absence of Notch signaling.

   Evidence Co-IP of RBPJ-L3MBTL3, competitive binding versus NOTCH ICD, H3K4me2 ChIP, and cross-species genetics in Drosophila and C. elegans

   PMID:29030483

   Open questions at the time

   • Structural basis of the RBPJ interface not yet resolved
   • Whether MBT methyllysine reading is required for RBPJ corepression not delineated
3. 2018 High

   Defined L3MBTL3 as a degradation adapter that reads methylated lysines on non-histone substrates and recruits CRL4DCAF5, linking lysine methylation to substrate proteostasis in development and pluripotency.

   Evidence Co-IP, site-directed mutagenesis of substrate lysines, in vivo ubiquitination, mouse knockout with DNA methylation/embryonic phenotype, and ES cell rescue assays for DNMT1, E2F1, and SOX2

   PMID:29691401 PMID:30442713

   Open questions at the time

   • Full substrate repertoire beyond DNMT1, E2F1, and SOX2 not mapped
   • Determinants of substrate selectivity by L3MBTL3-CRL4DCAF5 not defined
4. 2022 High

   Resolved the structural basis of corepression by showing L3MBTL3 binds RBPJ through an unusual motif distinct from other RBPJ partners.

   Evidence 2.06 Å crystal structure of the RBPJ-L3MBTL3-DNA ternary complex with structure-based mutagenesis and cellular validation

   PMID:36477367

   Open questions at the time

   • How LSD1 recruitment is geometrically coordinated with the RBPJ interface not shown
5. 2023 Medium

   Extended L3MBTL3's degradation role to hypoxia signaling, identifying a HIF-1α-induced negative feedback loop.

   Evidence Co-IP of L3MBTL3-HIF-1α, ubiquitination assay, and knockdown/overexpression under hypoxia

   PMID:36747531

   Open questions at the time

   • No in vitro reconstitution or interface mutagenesis
   • Whether CRL4DCAF5 mediates HIF-1α degradation not established
   • Methyllysine dependence not tested
6. 2025 Medium

   Demonstrated a methyllysine-independent function, showing L3MBTL3 can act through protein-protein interaction alone to drive oncogenic transcription.

   Evidence Co-IP and ChIP of L3MBTL3-STAT3 at the SNAIL promoter, Kme-binding mutant analysis, and metastasis assays in breast cancer

   PMID:39747894

   Open questions at the time

   • Single-lab study
   • How L3MBTL3 promotes STAT3-driven transcription mechanistically is unclear

• It remains unknown what governs the choice between L3MBTL3's degradation-adapter, corepressor, and methyllysine-independent transcriptional outputs, and the breadth of its substrate and chromatin targets is incompletely mapped.
• No unifying model for how reader activity is partitioned between proteolysis and corepression
• Proposed role at DNA damage sites rests only on a preprint proximity-labeling screen
• Engineered KRAB-L3MBTL3 silencing synergy lacks mechanistic dissection